CRL
Charles River Laboratories
278.10$
-1.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.1% | +23.3% | +10.5% | +22.0% | +15.7% | +11.5% | +21.1% | +12.3% | +3.9% | -1.9% | -0.9% | |
| – | +0.9% | +24.7% | +11.5% | +23.3% | +16.6% | +11.3% | +19.2% | +14.0% | +4.5% | +3.5% | +2.6% | |
| – | +12.4% | +21.3% | +8.8% | +19.9% | +14.1% | +12.0% | +24.3% | +9.6% | +2.7% | -11.4% | -8.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.2% | +30.1% | -0.8% | +15.1% | +15.8% | +8.8% | +17.2% | +7.3% | +12.8% | +0.1% | -3.7% | |
| – | +10.1% | +25.2% | +1.5% | +23.3% | +19.4% | +5.5% | +16.2% | +9.0% | +9.1% | +24.8% | -35.0% | |
| – | +16.2% | +15.1% | +21.4% | +15.0% | +6.0% | +23.2% | +36.3% | +10.4% | -5.2% | -63.2% | +123.4% | |
| – | +26.1% | +83.8% | +7.5% | +114.2% | -4.5% | +42.0% | -14.5% | -19.8% | +130.6% | -7.6% | -15.3% | |
| – | +10.0% | +14.1% | +33.2% | -5.1% | +8.0% | +47.0% | +7.5% | +29.6% | -6.7% | -84.0% | -206.9% | |
| – | -9.0% | +54.0% | +156.4% | -68.2% | -8.2% | +63.5% | +0.1% | +59.2% | -22.6% | -32.8% | -37.1% | |
| – | +17.8% | +3.7% | -20.3% | +83.5% | +11.3% | +44.6% | +7.3% | +24.4% | -2.4% | -97.8% | -1,501.7% | |
| – | +6.8% | +23.5% | +21.4% | +10.8% | +11.0% | +36.5% | +6.7% | +20.2% | +4.7% | -43.7% | -29.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.